Tom S Decates (Tom Decates, T Decates)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Hyaluronic Acid

Top Venues

Gels (Basel, Switzerland)

Aesthetic surgery journal

Journal of cosmetic dermatology

Dermatologic therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Tom S Decates, Konstantin Frank, Martin van Leerdam, Rutger H Schepers, Berend van der Lei
An Amazing Trend in the Number of Injectable Treatments in the Netherlands From 2016 to 2022. Aesthetic surgery journal 44 (4) (2024)
Paweł Kubik, Daniela Gallo, Maria Laura Tanda, Jerzy Jankau, Raffaele Rauso, Wojciech Gruszczyński, Aleksandra Pawłowska, Paweł Chrapczyński, Maciej Malinowski, Dariusz Grzanka, Marta Smolińska, Paulina Antosik, Maria-Luiza Piesiaków, Bartłomiej Łukasik, Agnieszka Pawłowska-Kubik, Giorgio Stabile, Stefania Guida, Łukasz Kodłubański, Tom S Decates, Nicola Zerbinati
Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records. Gels (Basel, Switzerland) 9 (6) (2023)
Tom S Decates, Konstantin Frank, Martin van Leerdam, Rutger H Schepers, Berend van der Lei
An Amazing Trend in the Number of Injectable Treatments in the Netherlands from 2016 - 2022. Aesthetic surgery journal (2023)
Paweł Kubik, Daniela Gallo, Maria Laura Tanda, Jerzy Jankau, Raffaele Rauso, Wojciech Gruszczyński, Aleksandra Pawłowska, Paweł Chrapczyński, Maciej Malinowski, Dariusz Grzanka, Marta Smolińska, Paulina Antosik, Maria-Luiza Piesiaków, Bartłomiej Łukasik, Agnieszka Pawłowska-Kubik, Giorgio Stabile, Stefania Guida, Łukasz Kodłubański, Tom S Decates, Nicola Zerbinati
Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records. Gels (Basel, Switzerland) 9 (6) (2023)
Paweł Kubik, Daniela Gallo, Maria Laura Tanda, Jerzy Jankau, Raffaele Rauso, Wojciech Gruszczyński, Aleksandra Pawłowska, Paweł Chrapczyński, Maciej Malinowski, Dariusz Grzanka, Marta Smolińska, Paulina Antosik, Maria-Luiza Piesiaków, Bartłomiej Łukasik, Agnieszka Pawłowska-Kubik, Giorgio Stabile, Stefania Guida, Łukasz Kodłubański, Tom S Decates, Nicola Zerbinati
Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records. Gels (Basel, Switzerland) 9 (6) (2023)
Tom S Decates, Peter J Velthuis, Renushka Jhingoerie, Susan Gibbs, Yara Bachour, Frank B Niessen
No association found between late-onset inflammatory adverse events after soft tissue filler injections and the adaptive immune system. Journal of cosmetic dermatology (2022)
Tom S Decates, Adriana M Villadiego Pereira, David G M Mosmuller, Peter J Velthuis
Pneumosinus dilatans following dermal filler injections. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 22 (6-8) (2021)
Tom S Decates, Jonathan A Kadouch, Konstantin Frank, Thomas Rustemeyer
Immediate nor Delayed Type Hypersensitivity Plays a Role in Late Inflammatory Reactions After Hyaluronic Acid Filler Injections. Clinical, cosmetic and investigational dermatology 14 (2021)
Tom S Decates, Konstantin Frank, Danial Zarringam, Luca Bruin, Rutger H Schepers, Berend van der Lei
Upward trend in number of injectable treatments in the Netherlands 2016-2019. Journal of cosmetic dermatology 20 (9) (2021)
Danial Zarringam, Tom S Decates, H P Slijper, P Velthuis
Increased usage of botulinum toxin and hyaluronic acid fillers in young adults. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (10) (2020)
Tom S Decates, Konstantin Frank, Leonie W Schelke, Neubury Lardy, Eduard Palou, Simó Schwartz, Yara Bachour, Frank B Niessen, Tamar E C Nijsten, Jaume Alijotas-Reig
Increased risk of late-onset, immune-mediated, adverse reactions related to dermal fillers in patients bearing HLA-B*08 and DRB1*03 haplotypes. Dermatologic therapy 34 (1) (2020)